Pharmadax Inc. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 17.720 million compared to TWD 13.857 million a year ago. Operating loss was TWD 226.951 million compared to TWD 231.294 million a year ago. Net loss was TWD 215.812 million compared to TWD 195.310 million a year ago. Basic loss per share was TWD 3.77 compared to TWD 3.53 a year ago.